Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Intravaginal testosterone cream improves sexual satisfaction and reduces vaginal discomfort in postmenopausal women on breast cancer treatment without affecting hormone levels.

The severity of symptoms in nonclassical congenital adrenal hyperplasia is not determined by CYP21A2 gene variations.

The conclusion is that treatments like finasteride and minoxidil can prevent baldness progression and improve hair density, but more research is needed on other therapies.

The study created a new method to test drugs that affect hormone processing in skin.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

A man developed male breast cancer after four years of finasteride treatment for an enlarged prostate.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

Protease Nexin-1 is found in human hair growth cells and is affected by male hormones.

Testosterone metabolism in balding scalp cells may not be the main cause of hair loss.

Testosterone's muscle-building effects do not require its conversion to DHT.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

AKR1C3 could be a treatment target for metabolic issues in PCOS.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Finasteride may cause kidney damage.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Finasteride and minoxidil work best together for hair loss.

Androgens prevent hair growth by changing Wnt signals in cells.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Finasteride doesn't affect bone density in male rats.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

Finasteride doesn't affect bone density in male rats.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Excess androgens may cause PCOS, not just be a symptom.